NDTDI

NDTDI, also known as 9-desmethine-LSD, 9-nor-LSD, or 8,10-seco-LSD, is a psychedelic drug related to lysergic acid diethylamide (LSD).^[1][2][3][4] It is a tricyclic cyclized tryptamine and partial lysergamide and is a structurally simplified analogue of LSD.^[2] The drug is specifically the analogue of LSD in which the carbon atom at position 9 of the ergoline ring system has been removed.^[2] It has been reported to produce psychedelic effects similarly to LSD, but with much lower potency.^[1] The pharmacology of NDTDI has not been studied. NDTDI was encountered as a novel designer drug by 2016.^[1][3][4]

Other namesN-(2-Diethylcarbamoylethyl)-N-methyl-4,α-methylenetryptamine; N-(3-Diethylamino-3-oxopropyl)-N-methyl-4,α-methylenetryptamine; 9-Nor-LSD; 9-Desmethine-LSD; 8,10-Seco-LSD

Drug classSerotonergic psychedelic; Hallucinogen; Simplified/partial LSD analogue

ATC code

• None

Legal status

• Illegal in Latvia

Quick facts Clinical data, Other names ...

NDTDI

Clinical data
Other names	N-(2-Diethylcarbamoylethyl)-N-methyl-4,α-methylenetryptamine; N-(3-Diethylamino-3-oxopropyl)-N-methyl-4,α-methylenetryptamine; 9-Nor-LSD; 9-Desmethine-LSD; 8,10-Seco-LSD
Drug class	Serotonergic psychedelic; Hallucinogen; Simplified/partial LSD analogue
ATC code	None
Legal status
Legal status	Illegal in Latvia
Identifiers
IUPAC name N,N-diethyl-3-(methyl(1,3,4,5-tetrahydrobenzo[cd]indol-4-yl)amino)propanamide
PubChem CID	163192742
CompTox Dashboard (EPA)	DTXSID601342245
Chemical and physical data
Formula	C19H27N3O
Molar mass	313.445 g·mol−1
3D model (JSmol)	Interactive image
SMILES CCN(CC)C(=O)CCN(C)C1Cc3cccc2ncc(C1)c23
InChI InChI=1S/C19H27N3O/c1-4-22(5-2)18(23)9-10-21(3)16-11-14-7-6-8-17-19(14)15(12-16)13-20-17/h6-8,13,16,20H,4-5,9-12H2,1-3H3 Key:JECGWOMOCPQHDH-UHFFFAOYSA-N

Close